Cargando…
Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19
The coronavirus disease 2019 (COVID-19) pandemic has led to 4,255,892 deaths worldwide. Although COVID-19 vaccines are available, mutant forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have reduced the effectiveness of vaccines. Patients with cancer are more vulnerable to COVID...
Autores principales: | Yang, Lu, Xiong, Hao, Li, Xin, Li, Yu, Zhou, Huanhuan, Lin, Xiao, Chan, Ting Fung, Li, Rong, Lai, Keng Po, Chen, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063984/ https://www.ncbi.nlm.nih.gov/pubmed/35520289 http://dx.doi.org/10.3389/fnut.2022.870370 |
Ejemplares similares
-
Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma
por: Li, Jun, et al.
Publicado: (2022) -
To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis
por: Wu, Ka, et al.
Publicado: (2019) -
Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis
por: Li, Rong, et al.
Publicado: (2022) -
Quantitation of the ROS production in plasma and radiation treatments of biotargets
por: Ji, Wan-Ook, et al.
Publicado: (2019) -
Long non-coding RNAs: a rising biotarget in colorectal cancer
por: Luo, Jian, et al.
Publicado: (2017)